Skip to main content
Home
Member Login
Join Our Contact Registry
RDCRN Alumni badge

Header Social Media

  • Our Research
    • Diseases Studied
    • Research Studies
    • Clinical Sites
    • Research Publications
    • Prior Research
  • Patients and Families
    • Patient Advocacy Groups
    • Resources for Patients and Families
    • Glossary
  • Researchers and Clinicians
    • Clinical Ambassadors
    • Funding Opportunities
    • Lectures
  • Early Stage Investigators
    • Funding Opportunities
    • Pilot and Feasibility Grants
    • Scholar Awards
    • Meet Our Early Stage Investigators
  • News and Events
    • Latest News
  • About Us
    • Our Consortium
    • Meet Our Team
    • Goals, Mission & Vision
    • Frequently Asked Questions
    • Contact Us
A Previously-Funded NIH Rare Diseases Clinical Research Network Consortium

Sugar blocks attached to proteins.

Footer menu

  • Web Policies
  • Genetic and Rare Diseases Information Center
  • Members Login
  • Contact Us

The Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) is a previously funded research group of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). FCDGC received funding under grant number U54NS115198 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Dietary Supplements (ODS). This website is hosted by the network's Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the FCDGC administrative coordinating center at Icahn School of Medicine at Mount Sinai, New York, and does not necessarily represent the official views of the NIH.